Literature DB >> 2902071

Benzodiazepine withdrawal: a review of the evidence.

R Noyes1, M J Garvey, B L Cook, P J Perry.   

Abstract

In a recent series of controlled studies, investigators looked at what happened when benzodiazepines were discontinued. Despite methodological problems, these studies showed that rebound anxiety occurred in a substantial minority of patients after several weeks of drug use. Also, a withdrawal syndrome developed in nearly half of patients who used benzodiazepines for more than a year. In these studies, risk factors included dose, duration of use, elimination rate of the drug, and abruptness of discontinuation. Patients who are physically dependent on benzodiazepines may need help in stopping these agents. Physicians should advise gradual discontinuation and, along with emotional support, should consider the use of alternative medications for the control of symptoms.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2902071

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  6 in total

1.  Hospital admission and start of benzodiazepine use.

Authors:  K Woodcock
Journal:  BMJ       Date:  1992-05-02

2.  Sex-related elevation in cortisol during chronic treatment with alprazolam associated with enhanced cognitive performance.

Authors:  Nunzio Pomara; Lisa M Willoughby; James C Ritchie; John J Sidtis; David J Greenblatt; Charles B Nemeroff
Journal:  Psychopharmacology (Berl)       Date:  2005-10-19       Impact factor: 4.530

3.  Neurologic Consequences of Drug Abuse: Recognizing the signs of neurotoxicity.

Authors:  M D Levitan
Journal:  Can Fam Physician       Date:  1992-02       Impact factor: 3.275

4.  Changes in "withdrawal symptoms" following discontinuation of low-dose diazepam.

Authors:  P Hayward; J Wardle; A Higgitt; J Gray
Journal:  Psychopharmacology (Berl)       Date:  1996-06       Impact factor: 4.530

5.  Antidepressants plus benzodiazepines for adults with major depression.

Authors:  Yusuke Ogawa; Nozomi Takeshima; Yu Hayasaka; Aran Tajika; Norio Watanabe; David Streiner; Toshi A Furukawa
Journal:  Cochrane Database Syst Rev       Date:  2019-06-03

Review 6.  Deprescribing benzodiazepines and Z-drugs in community-dwelling adults: a scoping review.

Authors:  André S Pollmann; Andrea L Murphy; Joel C Bergman; David M Gardner
Journal:  BMC Pharmacol Toxicol       Date:  2015-07-04       Impact factor: 2.483

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.